JP2006524483A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006524483A5 JP2006524483A5 JP2004559553A JP2004559553A JP2006524483A5 JP 2006524483 A5 JP2006524483 A5 JP 2006524483A5 JP 2004559553 A JP2004559553 A JP 2004559553A JP 2004559553 A JP2004559553 A JP 2004559553A JP 2006524483 A5 JP2006524483 A5 JP 2006524483A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorescence
- receptor
- protein
- hydroxy
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 23
- 108020003175 receptors Proteins 0.000 claims description 14
- 108091006027 G proteins Proteins 0.000 claims description 9
- 102000030782 GTP binding Human genes 0.000 claims description 9
- 108091000058 GTP-Binding Proteins 0.000 claims description 9
- 230000000694 effects Effects 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 7
- 230000003834 intracellular effect Effects 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
- 102100039215 Guanine nucleotide-binding protein G(t) subunit alpha-3 Human genes 0.000 claims description 5
- 229910052791 calcium Inorganic materials 0.000 claims description 5
- 108091005708 gustatory receptors Proteins 0.000 claims description 5
- 108010005995 gustducin Proteins 0.000 claims description 5
- 238000000423 cell based assay Methods 0.000 claims description 3
- 239000002299 complementary DNA Substances 0.000 claims description 3
- 102000037865 fusion proteins Human genes 0.000 claims description 3
- 108020001507 fusion proteins Proteins 0.000 claims description 3
- 210000004962 mammalian cell Anatomy 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 230000004913 activation Effects 0.000 description 13
- 102000005962 receptors Human genes 0.000 description 13
- 239000003446 ligand Substances 0.000 description 12
- -1 Glycyl- L -alanyl Chemical compound 0.000 description 6
- 239000004395 L-leucine Substances 0.000 description 6
- 229960003136 leucine Drugs 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- 235000019658 bitter taste Nutrition 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- HOVAGTYPODGVJG-ZFYZTMLRSA-N methyl alpha-D-glucopyranoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HOVAGTYPODGVJG-ZFYZTMLRSA-N 0.000 description 5
- 101000892439 Homo sapiens Taste receptor type 2 member 10 Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 3
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 3
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 3
- 101000787850 Homo sapiens Taste receptor type 2 member 38 Proteins 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 229910001424 calcium ion Inorganic materials 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000003146 transient transfection Methods 0.000 description 3
- 108010063331 type 2 taste receptors Proteins 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 101000887490 Homo sapiens Guanine nucleotide-binding protein G(z) subunit alpha Proteins 0.000 description 2
- 235000019454 L-leucine Nutrition 0.000 description 2
- VHLJDTBGULNCGF-UHFFFAOYSA-N Limonin Natural products CC1(C)OC2CC(=O)OCC23C4CCC5(C)C(CC(=O)C6OC56C4(C)C(=O)CC13)c7cocc7 VHLJDTBGULNCGF-UHFFFAOYSA-N 0.000 description 2
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 2
- NEZJDVYDSZTRFS-RMPHRYRLSA-N Phenyl beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1 NEZJDVYDSZTRFS-RMPHRYRLSA-N 0.000 description 2
- 102100025867 Taste receptor type 2 member 38 Human genes 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000001086 cytosolic effect Effects 0.000 description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 2
- PXLWOFBAEVGBOA-UHFFFAOYSA-N dihydrochalcone Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=CC(C(=O)CC(O)C=2C=CC(O)=CC=2)=C1O PXLWOFBAEVGBOA-UHFFFAOYSA-N 0.000 description 2
- KBDSLGBFQAGHBE-MSGMIQHVSA-N limonin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@@H]2[C@]34COC(=O)C[C@@H]3OC2(C)C)C=COC=1 KBDSLGBFQAGHBE-MSGMIQHVSA-N 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- JVYKIBAJVKEZSQ-UHFFFAOYSA-N (+)-13-hydroxylupanine Natural products C1N(C(CCC2)=O)C2C2CN3CCC(O)CC3C1C2 JVYKIBAJVKEZSQ-UHFFFAOYSA-N 0.000 description 1
- JVYKIBAJVKEZSQ-DHGKCCLASA-N 13-Hydroxylupanine Natural products C1N(C(CCC2)=O)[C@H]2[C@H]2CN3CC[C@@H](O)C[C@@H]3[C@@H]1C2 JVYKIBAJVKEZSQ-DHGKCCLASA-N 0.000 description 1
- JVYKIBAJVKEZSQ-RKQHYHRCSA-N 13-hydroxylupanine Chemical compound C1N(C(CCC2)=O)[C@H]2[C@H]2CN3CC[C@H](O)C[C@@H]3[C@@H]1C2 JVYKIBAJVKEZSQ-RKQHYHRCSA-N 0.000 description 1
- IMYAWDVGMAMZPE-UHFFFAOYSA-N 2-(3-hydroxy-4-methoxyphenyl)-1,3-benzodioxin-4-one Chemical compound C1=C(O)C(OC)=CC=C1C1OC2=CC=CC=C2C(=O)O1 IMYAWDVGMAMZPE-UHFFFAOYSA-N 0.000 description 1
- OTVWBLWXIXXGRE-UHFFFAOYSA-N 2-(3-hydroxy-4-methoxyphenyl)benzoic acid Chemical compound C1=C(O)C(OC)=CC=C1C1=CC=CC=C1C(O)=O OTVWBLWXIXXGRE-UHFFFAOYSA-N 0.000 description 1
- ZQTPOMUMEJTURV-UHFFFAOYSA-N 2-butoxy-5-nitroaniline Chemical compound CCCCOC1=CC=C([N+]([O-])=O)C=C1N ZQTPOMUMEJTURV-UHFFFAOYSA-N 0.000 description 1
- AMMPGYPPRLWMLW-UHFFFAOYSA-N 2-ethoxy-5-nitroaniline Chemical compound CCOC1=CC=C([N+]([O-])=O)C=C1N AMMPGYPPRLWMLW-UHFFFAOYSA-N 0.000 description 1
- NIPDVSLAMPAWTP-UHFFFAOYSA-N 2-methoxy-5-nitroaniline Chemical compound COC1=CC=C([N+]([O-])=O)C=C1N NIPDVSLAMPAWTP-UHFFFAOYSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- WVDUXAROXPYCEJ-UHFFFAOYSA-N 3-(3-hydroxy-4-methoxyphenyl)butanoic acid Chemical compound COC1=CC=C(C(C)CC(O)=O)C=C1O WVDUXAROXPYCEJ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 125000001999 4-Methoxybenzoyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C(*)=O 0.000 description 1
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 1
- LJTZPXOCBZRFBH-CIUDSAMLSA-N Ala-Ala-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N LJTZPXOCBZRFBH-CIUDSAMLSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- HDVAWXXJVMJBAR-UHFFFAOYSA-N Epilupinine Natural products C1CCCC2C(CO)CCCN21 HDVAWXXJVMJBAR-UHFFFAOYSA-N 0.000 description 1
- OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- WEWBWVMTOYUPHH-QHAQEBJBSA-N Lotaustralin Chemical compound CC[C@](C)(C#N)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WEWBWVMTOYUPHH-QHAQEBJBSA-N 0.000 description 1
- WEWBWVMTOYUPHH-HQPKYVJOSA-N Lotaustralin Natural products O([C@@](C#N)(CC)C)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 WEWBWVMTOYUPHH-HQPKYVJOSA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- FULZLIGZKMKICU-UHFFFAOYSA-N N-phenylthiourea Chemical compound NC(=S)NC1=CC=CC=C1 FULZLIGZKMKICU-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- NEZJDVYDSZTRFS-UHFFFAOYSA-N O-phenyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=CC=C1 NEZJDVYDSZTRFS-UHFFFAOYSA-N 0.000 description 1
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical compound OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 102100040649 Taste receptor type 2 member 10 Human genes 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- MMWCIQZXVOZEGG-HOZKJCLWSA-N [(1S,2R,3S,4S,5R,6S)-2,3,5-trihydroxy-4,6-diphosphonooxycyclohexyl] dihydrogen phosphate Chemical compound O[C@H]1[C@@H](O)[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](O)[C@H]1OP(O)(O)=O MMWCIQZXVOZEGG-HOZKJCLWSA-N 0.000 description 1
- HDVAWXXJVMJBAR-NXEZZACHSA-N [(1s,9ar)-2,3,4,6,7,8,9,9a-octahydro-1h-quinolizin-1-yl]methanol Chemical compound C1CCC[C@@H]2[C@@H](CO)CCCN21 HDVAWXXJVMJBAR-NXEZZACHSA-N 0.000 description 1
- UBRMQRLIHZXASZ-UHFFFAOYSA-N [K].OC1=CC(OCC[CH2])=CC(O)=C1C(=O)CCC1=CC=C(OC)C(O)=C1 Chemical class [K].OC1=CC(OCC[CH2])=CC(O)=C1C(=O)CCC1=CC=C(OC)C(O)=C1 UBRMQRLIHZXASZ-UHFFFAOYSA-N 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- JYIJIIVLEOETIQ-UHFFFAOYSA-N alpha-Isolupanin Natural products C12CCCCN2CC2C3CCCC(=O)N3CC1C2 JYIJIIVLEOETIQ-UHFFFAOYSA-N 0.000 description 1
- QLTCHMYAEJEXBT-UHFFFAOYSA-N alpha-beta-D-glucopyranosyloxy-isobutyronitrile Natural products N#CC(C)(C)OC1OC(CO)C(O)C(O)C1O QLTCHMYAEJEXBT-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- BNBQRQQYDMDJAH-UHFFFAOYSA-N benzodioxan Chemical compound C1=CC=C2OCCOC2=C1 BNBQRQQYDMDJAH-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 102000052301 human GNAZ Human genes 0.000 description 1
- 102000056291 human TAS2R10 Human genes 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- KFKWRHQBZQICHA-UHFFFAOYSA-N leucyl-phenylalanine Chemical compound CC(C)CC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-UHFFFAOYSA-N 0.000 description 1
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 1
- CRTWQTRFSBJGLK-UHFFFAOYSA-N linamarin Natural products CC(C)(C#N)C1OC(CO)C(O)C(O)C1O CRTWQTRFSBJGLK-UHFFFAOYSA-N 0.000 description 1
- QLTCHMYAEJEXBT-ZEBDFXRSSA-N linamarin Chemical compound N#CC(C)(C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QLTCHMYAEJEXBT-ZEBDFXRSSA-N 0.000 description 1
- JYIJIIVLEOETIQ-XDQVBPFNSA-N lupanine Chemical compound C([C@H]12)CCCN1C[C@H]1[C@H]3CCCC(=O)N3C[C@@H]2C1 JYIJIIVLEOETIQ-XDQVBPFNSA-N 0.000 description 1
- PXSNOBCUERDYST-UHFFFAOYSA-N lupanine Natural products O=C1CCCN2CC3CC(CC12)N4CCCCC34 PXSNOBCUERDYST-UHFFFAOYSA-N 0.000 description 1
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 108091006082 receptor inhibitors Proteins 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 235000019583 umami taste Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012130 whole-cell lysate Substances 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43479002P | 2002-12-18 | 2002-12-18 | |
| PCT/CH2003/000830 WO2004055048A2 (en) | 2002-12-18 | 2003-12-17 | Chimeric alpha q-gustducin g-proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010016775A Division JP5425651B2 (ja) | 2002-12-18 | 2010-01-28 | キメラアルファｑ−ガストデューシンｇタンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006524483A JP2006524483A (ja) | 2006-11-02 |
| JP2006524483A5 true JP2006524483A5 (https=) | 2007-02-08 |
| JP4654038B2 JP4654038B2 (ja) | 2011-03-16 |
Family
ID=32595305
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004559553A Expired - Lifetime JP4654038B2 (ja) | 2002-12-18 | 2003-12-17 | キメラアルファｑ−ガストデューシンｇタンパク質 |
| JP2010016775A Expired - Lifetime JP5425651B2 (ja) | 2002-12-18 | 2010-01-28 | キメラアルファｑ−ガストデューシンｇタンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010016775A Expired - Lifetime JP5425651B2 (ja) | 2002-12-18 | 2010-01-28 | キメラアルファｑ−ガストデューシンｇタンパク質 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7919236B2 (https=) |
| EP (1) | EP1581555B1 (https=) |
| JP (2) | JP4654038B2 (https=) |
| CN (1) | CN1726224A (https=) |
| AT (1) | ATE393778T1 (https=) |
| AU (1) | AU2003286069A1 (https=) |
| CA (1) | CA2507387A1 (https=) |
| DE (1) | DE60320682T2 (https=) |
| ES (1) | ES2305536T3 (https=) |
| WO (1) | WO2004055048A2 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7368285B2 (en) | 2001-03-07 | 2008-05-06 | Senomyx, Inc. | Heteromeric umami T1R1/T1R3 taste receptors and isolated cells that express same |
| DK2327985T3 (en) | 2001-06-26 | 2016-09-05 | Senomyx Inc | H1 Oligomeric T1R Taste Receptors and Cell Lines Expressing the Receptors, and Their Use to Identify Taste Compounds |
| AU2003286069A1 (en) * | 2002-12-18 | 2004-07-09 | Givaudan Sa | Chimeric alpha q-gustducin g-proteins |
| WO2006046854A2 (en) | 2004-10-29 | 2006-05-04 | Quest International B.V. | Flavour modulating substances |
| BRPI0518075B8 (pt) | 2004-10-29 | 2017-05-16 | Quest Int Services B V | composição flavorizante, produto, e, processo de melhorar o flavor de um alimento, de uma bebida ou de um produto farmacêutico |
| DE602005015849D1 (de) | 2005-09-02 | 2009-09-17 | Givaudan Nederland Services B | Geschmackverstärker |
| WO2007121604A2 (en) | 2006-04-20 | 2007-11-01 | Givaudan Sa | Method relating to sweetness enhancement |
| US20110097741A1 (en) * | 2006-04-20 | 2011-04-28 | Jay Patrick Slack | Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays |
| JP2009533065A (ja) * | 2006-04-20 | 2009-09-17 | ジボダン エス エー | 味覚物質同定のための機能的方法 |
| ATE444280T1 (de) | 2006-05-05 | 2009-10-15 | Givaudan Nederland Services B | Zusammensetzung zur verbesserung von geschmack |
| US8039233B2 (en) * | 2007-01-18 | 2011-10-18 | Givaudan S.A. | Nucleic acid sequences and their use in methods to identify umami modulatiors |
| EP1975611A1 (en) | 2007-03-29 | 2008-10-01 | Deutsches Institut für Ernährungsforschung Potsdam -Rehbrücke-Stiftung des öffentlichen Rechts- Vertreten durch den Stiftungsvorstand | Agonists of bitter taste receptors and uses thereof |
| EP2137322B1 (en) * | 2007-03-30 | 2013-02-27 | Givaudan SA | Methods to identify tas2r modulators |
| KR20100131969A (ko) * | 2007-12-10 | 2010-12-16 | 메타프로테오믹스, 엘엘씨 | 암, 혈관신생 및 이와 관련된 염증 경로의 치환된 1,3-시클로펜타디온 다중-표적 단백질 키나아제 조절제 |
| EP2108954A1 (en) | 2008-04-10 | 2009-10-14 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | A test system for detecting intracellular cyclic nucleotide level and methods and uses thereof |
| US8546085B2 (en) * | 2008-06-13 | 2013-10-01 | Givaudan Sa | Methods of identifying modulators of the bitter taste receptor TAS2R44 |
| JP5576653B2 (ja) * | 2008-12-26 | 2014-08-20 | サントリー食品インターナショナル株式会社 | 環状ジペプチド含有飲料 |
| EP2924112A1 (en) * | 2009-02-02 | 2015-09-30 | Chromocell Corporation | Novel cell lines and methods |
| US20130123135A1 (en) | 2010-05-07 | 2013-05-16 | Jay Patrick Slack | Methods To Identify Modulators of TAS2R48 Receptors |
| US20130115624A1 (en) | 2010-05-07 | 2013-05-09 | Givaudan S.A. | Methods To Identify Modulators |
| JP5906013B2 (ja) * | 2010-12-10 | 2016-04-20 | 花王株式会社 | 苦味抑制剤の評価・選択方法 |
| EP2661266B1 (en) | 2011-01-07 | 2020-09-16 | Anji Pharma (US) LLC | Chemosensory receptor ligand-based therapies |
| US9795792B2 (en) | 2011-02-25 | 2017-10-24 | Medtronic, Inc. | Emergency mode switching for non-pacing modes |
| US9128079B2 (en) | 2011-08-08 | 2015-09-08 | The Coca-Cola Company | Methods of using lung or bronchial epithelial cells to identify bitter taste modulators |
| WO2013072332A1 (en) | 2011-11-14 | 2013-05-23 | Givaudan Sa | Methods of using antagonists of bitter taste receptors |
| KR20190120430A (ko) | 2012-01-06 | 2019-10-23 | 엘셀릭스 테라퓨틱스 인코포레이티드 | 바이구아나이드 조성물 및 대사 장애를 치료하는 방법 |
| EP2800562A2 (en) | 2012-01-06 | 2014-11-12 | Elcelyx Therapeutics, Inc. | Compositions and methods for treating metabolic disorders |
| HK1210825A1 (en) | 2012-07-11 | 2016-05-06 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| CN105101956B (zh) | 2013-01-05 | 2018-12-07 | 埃尔舍利克斯治疗公司 | 包含双胍的延迟释放组合物 |
| EP2983507B1 (en) | 2013-03-15 | 2020-04-22 | Applied Food Biotechnology, Inc. | Feline bitter taste receptors and methods |
| US9804157B1 (en) | 2013-03-15 | 2017-10-31 | Senomyx, Inc. | Screening assays to identify compounds which modulate T1R associated taste modalities which eliminate false positives |
| JP6367315B2 (ja) * | 2013-05-10 | 2018-08-01 | ペプシコ, インコーポレイテッドPepsiCo Inc. | 潜在的味覚調節物質を特定するためのモデルとしての細胞 |
| WO2014183041A1 (en) | 2013-05-10 | 2014-11-13 | Pepsico, Inc. | Taste receptor internalization assay |
| JP6755640B2 (ja) | 2014-03-28 | 2020-09-16 | 味の素株式会社 | 甘味受容体キメラタンパク質及びその利用 |
| WO2017066799A1 (en) * | 2015-10-16 | 2017-04-20 | Cornell University | Sweeteners having enhanced organoleptic properties |
| JP6924590B2 (ja) * | 2016-03-14 | 2021-08-25 | サントリーホールディングス株式会社 | 苦味評価のための融合タンパク質および苦味評価方法 |
| CN108611324A (zh) * | 2018-05-07 | 2018-10-02 | 云南中烟工业有限责任公司 | 一种稳定共表达重组人源甜味受体蛋白的真核细胞系及其制备方法 |
| WO2025183058A1 (ja) * | 2024-02-29 | 2025-09-04 | 味の素株式会社 | 植物由来タンパク質含有食品における異味・異風味をマスキングする物質のスクリーニング方法および異味・異風味のマスキング用の組成物 |
| CN119193656A (zh) * | 2024-09-24 | 2024-12-27 | 上海交通大学 | 一种响应鲜味信号的酵母细胞模型及其制备方法与应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5817759A (en) * | 1992-04-09 | 1998-10-06 | Linguagen Corporation | Gustducin polypeptides and fragments |
| EP1214343A2 (en) | 1999-09-10 | 2002-06-19 | The Regents Of The University Of California | T2r taste receptor family |
| US6462178B1 (en) * | 1999-11-17 | 2002-10-08 | Yong Hou Wong | G protein |
| WO2002036622A2 (en) | 2000-10-30 | 2002-05-10 | Senomyx, Inc. | GαqPROETIN VARIANTS AND THEIR USE IN THE ANALYSIS AND DISCOVERY OF AGONISTS AND ANTAGONISTS OF CHEMOSENSORY RECEPTORS |
| US7041457B2 (en) * | 2000-10-30 | 2006-05-09 | Senomyx, Inc. | Gαq protein variants and their use in the analysis and discovery of agonists and antagonists of chemosensory receptors |
| AU2003286069A1 (en) * | 2002-12-18 | 2004-07-09 | Givaudan Sa | Chimeric alpha q-gustducin g-proteins |
-
2003
- 2003-12-17 AU AU2003286069A patent/AU2003286069A1/en not_active Abandoned
- 2003-12-17 CA CA002507387A patent/CA2507387A1/en not_active Abandoned
- 2003-12-17 AT AT03776743T patent/ATE393778T1/de not_active IP Right Cessation
- 2003-12-17 JP JP2004559553A patent/JP4654038B2/ja not_active Expired - Lifetime
- 2003-12-17 US US10/538,038 patent/US7919236B2/en not_active Expired - Lifetime
- 2003-12-17 EP EP03776743A patent/EP1581555B1/en not_active Expired - Lifetime
- 2003-12-17 CN CNA2003801065075A patent/CN1726224A/zh active Pending
- 2003-12-17 ES ES03776743T patent/ES2305536T3/es not_active Expired - Lifetime
- 2003-12-17 WO PCT/CH2003/000830 patent/WO2004055048A2/en not_active Ceased
- 2003-12-17 DE DE60320682T patent/DE60320682T2/de not_active Expired - Lifetime
-
2010
- 2010-01-28 JP JP2010016775A patent/JP5425651B2/ja not_active Expired - Lifetime
-
2011
- 2011-02-25 US US13/035,435 patent/US8609362B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006524483A5 (https=) | ||
| JP5425651B2 (ja) | キメラアルファｑ−ガストデューシンｇタンパク質 | |
| Hill et al. | Differential activation of c‐fos promoter elements by serum, lysophosphatidic acid, G proteins and polypeptide growth factors. | |
| Galson et al. | The orphan receptor hepatic nuclear factor 4 functions as a transcriptional activator for tissue-specific and hypoxia-specific erythropoietin gene expression and is antagonized by EAR3/COUP-TF1 | |
| Liu et al. | Acidic stimuli activates two distinct pathways in taste receptor cells from rat fungiform papillae | |
| JP2005500836A (ja) | 組換え宿主細胞における機能性ヒト嗅覚器環状ヌクレオチドゲート（ｃｎｇ）チャンネルの発現及び嗅覚調節物質を特定するための細胞を用いるアッセイにおけるその使用 | |
| KR101356892B1 (ko) | 미각자극물질을 동정하는 기능적인 방법 | |
| US7208290B2 (en) | Methods of co-expressing umami taste receptors and chimeric Gα15 variants | |
| JP2007507544A (ja) | 哺乳動物ｔ１ｒ３甘味レセプター | |
| Hacker et al. | Evidence for two populations of bitter responsive taste cells in mice | |
| CN105917228A (zh) | 鉴定嗅觉受体调节剂的方法 | |
| US20080124753A1 (en) | SpiceMatrix Technology for Taste Compound Identification | |
| Monastyrskaia et al. | Effect of the umami peptides on the ligand binding and function of rat mGlu4a receptor might implicate this receptor in the monosodium glutamate taste transduction | |
| JP2009544330A (ja) | Ｒｇｓ２１活性の調節物質を同定するための方法、ｒｇｓ２１調節物質を含む組成物、および味覚を調節するためのその使用方法 | |
| JP2009534017A (ja) | 核酸、ポリペプチドおよびその利用 | |
| JP6122858B2 (ja) | 苦味を調整する化合物を同定するための検定 | |
| US20090142793A1 (en) | Screening assay to identify modulators of the sleep/wake cycle | |
| Mitchell et al. | Dexamethasone increases G alpha q-11 expression and hormone-stimulated phospholipase C activity in UMR-106-01 cells. | |
| EP1102844A2 (en) | Human neuronal acid-sensitive cationic channel, its cloning and applications | |
| Hong et al. | Molecular cloning and characterization of mouse cardiac junctate isoforms | |
| JP6461901B2 (ja) | ネコ科苦味受容体及び方法 | |
| JP2009544282A (ja) | 塩味のエンハンサーまたはマスカーをスクリーニングするための方法 | |
| JP5219146B2 (ja) | 哺乳動物における新規ｓｌｃ１７型トランスポータータンパク質およびその利用 | |
| JP5281039B2 (ja) | 単一分子で機能する分枝鎖中性アミノ酸トランスポーター | |
| JP2008529987A (ja) | 塩味受容体、および塩味覚のアッセイにおけるその使用 |